AMRN - Amarin Corporation PLC logo

AMRN

Amarin Corporation PLC

Amarin Corporation develops and commercializes therapeutics for cardiovascular diseases, focusing on VASCEPA, a prescription omega-3 fatty acid used to lower triglyceride levels in patients. It sells primarily through wholesalers and pharmacies globally.

โš•๏ธ Healthcare NASDAQ Listed 1993 $ USD
$1,000 invested 30 years ago โ†’$1today

Score Overview

1 Year
Score
Net Growth30.09%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth-13.71%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score2.6
Net Growth-450.92%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth-68.39%
Rev TrendNever
Revenue Consistencyโ€”
10 Years
Score
Net Growth68.59%
Net Trend70%
Net Income Consistency
Rev Growth41.72%
Rev Trend40%
Revenue Consistency
20 Years
Score4.0
Net Growth-0.75%
Net Trend60%
Net Income Consistency
Rev Growth368x
Rev Trend57%
Revenue Consistency
30 Years
Score
Net Growth-73.86%
Net Trend53%
Net Income Consistency
Rev Growth8x
Rev Trend50%
Revenue Consistency
All Time
Score
Net Growth-30x
Net Trend55%
Net Income Consistency
Rev Growth12x
Rev Trend52%
Revenue Consistency

See the full market ranking โ†’

Amarin Corporation PLC fundamental performance

Between 2015 and 2025, revenue grew from $ 81M to $ 213M and net income went from -$ 115M to -$ 38M. Revenue increased in 4 of those 10 years; net income in 7.

Between 2005 and 2025, revenue grew from $ 500K to $ 213M and net income went from -$ 20M to -$ 38M. Revenue increased in 11 of those 20 years; net income in 12.

Amarin Corporation PLC currently holds a 20-year HDB Score of 4.0 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-13
$ 14.15โ€”
1 Year2025-08-13
$ 15.00-5.67%
5 Years2021-08-13
$ 108.40-86.95%
10 Years2016-08-12
$ 61.40-76.95%
20 Years2006-08-11
$ 592.00-97.61%
30 Years1996-08-13
$ 15.25K-99.91%
All Time1993-04-01
$ 12K-99.88%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 184M-$ 27M
2025$ 213M-$ 38M$ 302M
2024$ 228M-$ 82M$ 294M
2023$ 306M-$ 59M$ 320M
2022$ 369M-$ 105M$ 309M
2021$ 583M$ 7M$ 454M
2020$ 614M-$ 18M$ 500M
2019$ 429M-$ 22M$ 644M
2018$ 229M-$ 116M$ 249M
2017$ 181M-$ 67M$ 73M
2016$ 130M-$ 86M$ 98M
2015$ 81M-$ 115M$ 106M
2014$ 54M-$ 56M$ 119M
2013$ 26M-$ 166M$ 191M
2012-$ 179M$ 260M
2011-$ 69M$ 116M
2010-$ 249M$ 31M
2009-$ 59M$ 52M
2008-$ 20M$ 11M
2007$ 7M-$ 38M$ 18M
2006$ 500K-$ 26M$ 36M
2005$ 500K-$ 20M$ 33M
2004$ 1M$ 3M$ 10M
2003$ 7M-$ 19M$ 2M
2002$ 65M-$ 37M$ 24M
2001$ 4M-$ 4M$ 30M
2000$ 15M$ 2M$ 2M
1999$ 11M$ 4M$ 1M
1998$ 10M-$ 28M$ 800K
1997$ 24M-$ 7M$ 5M
1996$ 21M-$ 15M$ 4M
1995$ 29M$ 4M$ 12M
1994$ 18M$ 2M
IPO1993$ 14M$ 900K$ 9M

Explore beyond AMRN

You're looking at Amarin Corporation PLC. Members apply the same fundamental framework across all 3,859 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies